Study reveals how inflammatory immune cells enhance prostate cancer resistance

There is a challenge related to prostate and many other cancers that cancer cells form resistance to treatments as the disease progresses. However, these resistance mechanisms are not yet fully understood.

Vitamin D-MS Link; Nootropic Gummies Laced With Psilocybin; Forecasting Seizures

Vitamin D levels before starting treatment were tied to subsequent multiple sclerosis (MS) disease activity. (Journal of Neurology, Neurosurgery, and Psychiatry) Several brands of nootropic

July 24, 2024

J&J expects strong procedure volumes in 2024

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. By the numbers Q4 MedTech sales: $7.67

January 23, 2024

Daiichi, Alteogen to work on subcutaneous Enhertu; Roche ends Nykode deal

Plus, news about Disc Medicine, AlloVir, Kalaris, Travere Therapeutics and Trevena: Daiichi Sankyo, Alteogen to develop subcutaneous version of Enhertu: Daiichi will pay $20 million

November 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.